Incannex Announces Participation at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference June 26, 2023
Event: H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
Date: June 26, 2023
Related Posts
Update on Nasdaq initial public offering in the United States
Incannex -IHL-675A Phase 1 clinical trial to assess safety and pharmacokinetics as a potential anti-inflammatory drug candidate
IHL : Pre-IND meeting granted with the US FDA regarding IHL-675A for use in preventing ARDS and SAARDS
